Measurements of Selected Brominated Flame Retardants in Nursing Women: Implications for Human Exposure
Identifieur interne : 000060 ( PascalFrancis/Corpus ); précédent : 000059; suivant : 000061Measurements of Selected Brominated Flame Retardants in Nursing Women: Implications for Human Exposure
Auteurs : Simon Ningsun Zhou ; Angelina Buchar ; Shabana Siddique ; Larissa Takser ; Nadia Abdelouahab ; JIPING ZHUSource :
- Environmental science & technology [ 0013-936X ] ; 2014.
Descripteurs français
- Pascal (Inist)
English descriptors
- KwdEn :
Abstract
We have examined several emerging brominated flame retardants (BFRs) including 2-ethyl-1-hexyl-2,3,4,5-tetrabromobenzoate (TBB), bis(2-ethylhexyl) tetrabromophthalate (TBPH), 1,2-bis(2,4,6-tribromophenoxy) ethane (BTBPE), 4,5,6,7-tetrabromo-1,1,3-trimethyl-3-(2,3,4,5-tetrabromophenyl)-indane (OBIND), and decabromodiphenyl ethane (DBDPE) in paired human maternal serum (n = 102) and breast milk (n = 105) collected in 2008-2009 in the Sherbrooke region in Canada. Three legacy BFRs were also included in the study for comparison: decabromobiphenyl (BB-209), 2,2',4,4',5,5'-hexabromobiphenyl (BB-153), and 2,2',4,4',5,5'-hexabromodiphenyl ethers (BDE-153). TBB, BB-153, and BDE-153 had detection frequencies greater than 55% in both serum and milk samples. Their lipid weight (lw) adjusted median concentrations (ng g-1 lw) in serum and milk were 1.6 and 0.41 for TBB, 0.48 and 0.31 for BB-153, and 1.5 and 4.4 for BDE-153, respectively. The detection frequencies for the other BFRs measured in serum and milk were 16.7% and 32.4% for TBPH, 3.9% and 0.0% for BTBPE, 2.0% and 0.0% for BB-209, 9.8% and 1.0% for OBIND, and 5.9% and 8.6% for DBDPE. The ratio of TBB over the sum of TBB and TBPH (f.TBB) in serum (0.23) was lower than that in milk (0.46), indicating TBB has a larger tendency than TBPH to be redistributed from blood to milk. Overall, these data confirm the presence of non-PBDE BFRs in humans, and the need to better understand their sources, routes of exposure, and potential human health effects.
Notice en format standard (ISO 2709)
Pour connaître la documentation sur le format Inist Standard.
| pA |
|
|---|
Format Inist (serveur)
| NO : | PASCAL 15-0038201 INIST |
|---|---|
| ET : | Measurements of Selected Brominated Flame Retardants in Nursing Women: Implications for Human Exposure |
| AU : | NINGSUN ZHOU (Simon); BUCHAR (Angelina); SIDDIQUE (Shabana); TAKSER (Larissa); ABDELOUAHAB (Nadia); JIPING ZHU; STERN (Paul C.); WEBLER (Thomas); SMALL (Mitchell J.) |
| AF : | Exposure and Biomonitoring Division, Health Canada/Ottawa, Ontario K1A 0K9/Canada (1 aut., 3 aut., 6 aut.); Existing Substances Risk Assessment Bureau, Health Canada/Ottawa, Ontario K1A 0K9/Canada (2 aut.); Département de Pédiatrie, Faculté de Médecine, Université de Sherbrooke/Sherbrooke, Québec J1K 2R1/Canada (4 aut., 5 aut.); National Research Council, Board on Environmental Change and Society/Washington, DC20001/Etats-Unis (1 aut.); Social and Environmental Research Institute/Amherst, Massachusetts 01002/Etats-Unis (2 aut.); H. John Heinz III Professor of Environmental Engineering, Carnegie Mellon University/Pittsburgh, Pennsylvania 15213/Etats-Unis (3 aut.) |
| DT : | Publication en série; Niveau analytique |
| SO : | Environmental science & technology; ISSN 0013-936X; Coden ESTHAG; Etats-Unis; Da. 2014; Vol. 48; No. 15; Pp. 8873-8880; Bibl. 56 ref. |
| LA : | Anglais |
| EA : | We have examined several emerging brominated flame retardants (BFRs) including 2-ethyl-1-hexyl-2,3,4,5-tetrabromobenzoate (TBB), bis(2-ethylhexyl) tetrabromophthalate (TBPH), 1,2-bis(2,4,6-tribromophenoxy) ethane (BTBPE), 4,5,6,7-tetrabromo-1,1,3-trimethyl-3-(2,3,4,5-tetrabromophenyl)-indane (OBIND), and decabromodiphenyl ethane (DBDPE) in paired human maternal serum (n = 102) and breast milk (n = 105) collected in 2008-2009 in the Sherbrooke region in Canada. Three legacy BFRs were also included in the study for comparison: decabromobiphenyl (BB-209), 2,2',4,4',5,5'-hexabromobiphenyl (BB-153), and 2,2',4,4',5,5'-hexabromodiphenyl ethers (BDE-153). TBB, BB-153, and BDE-153 had detection frequencies greater than 55% in both serum and milk samples. Their lipid weight (lw) adjusted median concentrations (ng g-1 lw) in serum and milk were 1.6 and 0.41 for TBB, 0.48 and 0.31 for BB-153, and 1.5 and 4.4 for BDE-153, respectively. The detection frequencies for the other BFRs measured in serum and milk were 16.7% and 32.4% for TBPH, 3.9% and 0.0% for BTBPE, 2.0% and 0.0% for BB-209, 9.8% and 1.0% for OBIND, and 5.9% and 8.6% for DBDPE. The ratio of TBB over the sum of TBB and TBPH (f.TBB) in serum (0.23) was lower than that in milk (0.46), indicating TBB has a larger tendency than TBPH to be redistributed from blood to milk. Overall, these data confirm the presence of non-PBDE BFRs in humans, and the need to better understand their sources, routes of exposure, and potential human health effects. |
| CC : | 002B03L06 |
| FD : | Retardateur flamme; Brome composé organique; Brome Composé organique; Passage lait; Santé publique; Santé et environnement; Mesure concentration; Liquide biologique; Mère; Lait maternel; Canada; Polluant émergent |
| FG : | Amérique du Nord; Amérique; Composé organique |
| ED : | Flame retardant; Organic bromine compounds; Bromine Organic compounds; Milk transfer; Public health; Health and environment; Concentration measurement; Biological fluid; Mother; Breast milk; Canada; Emerging pollutant |
| EG : | North America; America; Organic compounds |
| SD : | Retardador llama; Bromo Compuesto orgánico; Paso leche; Salud pública; Salud y medio ambiente; Medición concentración; Líquido biológico; Madre; Leche materna; Canadá |
| LO : | INIST-13615.354000504883950660 |
| ID : | 15-0038201 |
Links to Exploration step
Pascal:15-0038201Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Measurements of Selected Brominated Flame Retardants in Nursing Women: Implications for Human Exposure</title><author><name sortKey="Ningsun Zhou, Simon" sort="Ningsun Zhou, Simon" uniqKey="Ningsun Zhou S" first="Simon" last="Ningsun Zhou">Simon Ningsun Zhou</name><affiliation><inist:fA14 i1="01"><s1>Exposure and Biomonitoring Division, Health Canada</s1><s2>Ottawa, Ontario K1A 0K9</s2><s3>CAN</s3><sZ>1 aut.</sZ><sZ>3 aut.</sZ><sZ>6 aut.</sZ></inist:fA14></affiliation></author><author><name sortKey="Buchar, Angelina" sort="Buchar, Angelina" uniqKey="Buchar A" first="Angelina" last="Buchar">Angelina Buchar</name><affiliation><inist:fA14 i1="02"><s1>Existing Substances Risk Assessment Bureau, Health Canada</s1><s2>Ottawa, Ontario K1A 0K9</s2><s3>CAN</s3><sZ>2 aut.</sZ></inist:fA14></affiliation></author><author><name sortKey="Siddique, Shabana" sort="Siddique, Shabana" uniqKey="Siddique S" first="Shabana" last="Siddique">Shabana Siddique</name><affiliation><inist:fA14 i1="01"><s1>Exposure and Biomonitoring Division, Health Canada</s1><s2>Ottawa, Ontario K1A 0K9</s2><s3>CAN</s3><sZ>1 aut.</sZ><sZ>3 aut.</sZ><sZ>6 aut.</sZ></inist:fA14></affiliation></author><author><name sortKey="Takser, Larissa" sort="Takser, Larissa" uniqKey="Takser L" first="Larissa" last="Takser">Larissa Takser</name><affiliation><inist:fA14 i1="03"><s1>Département de Pédiatrie, Faculté de Médecine, Université de Sherbrooke</s1><s2>Sherbrooke, Québec J1K 2R1</s2><s3>CAN</s3><sZ>4 aut.</sZ><sZ>5 aut.</sZ></inist:fA14></affiliation></author><author><name sortKey="Abdelouahab, Nadia" sort="Abdelouahab, Nadia" uniqKey="Abdelouahab N" first="Nadia" last="Abdelouahab">Nadia Abdelouahab</name><affiliation><inist:fA14 i1="03"><s1>Département de Pédiatrie, Faculté de Médecine, Université de Sherbrooke</s1><s2>Sherbrooke, Québec J1K 2R1</s2><s3>CAN</s3><sZ>4 aut.</sZ><sZ>5 aut.</sZ></inist:fA14></affiliation></author><author><name sortKey="Jiping Zhu" sort="Jiping Zhu" uniqKey="Jiping Zhu" last="Jiping Zhu">JIPING ZHU</name><affiliation><inist:fA14 i1="01"><s1>Exposure and Biomonitoring Division, Health Canada</s1><s2>Ottawa, Ontario K1A 0K9</s2><s3>CAN</s3><sZ>1 aut.</sZ><sZ>3 aut.</sZ><sZ>6 aut.</sZ></inist:fA14></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">INIST</idno><idno type="inist">15-0038201</idno><date when="2014">2014</date><idno type="stanalyst">PASCAL 15-0038201 INIST</idno><idno type="RBID">Pascal:15-0038201</idno><idno type="wicri:Area/PascalFrancis/Corpus">000060</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Measurements of Selected Brominated Flame Retardants in Nursing Women: Implications for Human Exposure</title><author><name sortKey="Ningsun Zhou, Simon" sort="Ningsun Zhou, Simon" uniqKey="Ningsun Zhou S" first="Simon" last="Ningsun Zhou">Simon Ningsun Zhou</name><affiliation><inist:fA14 i1="01"><s1>Exposure and Biomonitoring Division, Health Canada</s1><s2>Ottawa, Ontario K1A 0K9</s2><s3>CAN</s3><sZ>1 aut.</sZ><sZ>3 aut.</sZ><sZ>6 aut.</sZ></inist:fA14></affiliation></author><author><name sortKey="Buchar, Angelina" sort="Buchar, Angelina" uniqKey="Buchar A" first="Angelina" last="Buchar">Angelina Buchar</name><affiliation><inist:fA14 i1="02"><s1>Existing Substances Risk Assessment Bureau, Health Canada</s1><s2>Ottawa, Ontario K1A 0K9</s2><s3>CAN</s3><sZ>2 aut.</sZ></inist:fA14></affiliation></author><author><name sortKey="Siddique, Shabana" sort="Siddique, Shabana" uniqKey="Siddique S" first="Shabana" last="Siddique">Shabana Siddique</name><affiliation><inist:fA14 i1="01"><s1>Exposure and Biomonitoring Division, Health Canada</s1><s2>Ottawa, Ontario K1A 0K9</s2><s3>CAN</s3><sZ>1 aut.</sZ><sZ>3 aut.</sZ><sZ>6 aut.</sZ></inist:fA14></affiliation></author><author><name sortKey="Takser, Larissa" sort="Takser, Larissa" uniqKey="Takser L" first="Larissa" last="Takser">Larissa Takser</name><affiliation><inist:fA14 i1="03"><s1>Département de Pédiatrie, Faculté de Médecine, Université de Sherbrooke</s1><s2>Sherbrooke, Québec J1K 2R1</s2><s3>CAN</s3><sZ>4 aut.</sZ><sZ>5 aut.</sZ></inist:fA14></affiliation></author><author><name sortKey="Abdelouahab, Nadia" sort="Abdelouahab, Nadia" uniqKey="Abdelouahab N" first="Nadia" last="Abdelouahab">Nadia Abdelouahab</name><affiliation><inist:fA14 i1="03"><s1>Département de Pédiatrie, Faculté de Médecine, Université de Sherbrooke</s1><s2>Sherbrooke, Québec J1K 2R1</s2><s3>CAN</s3><sZ>4 aut.</sZ><sZ>5 aut.</sZ></inist:fA14></affiliation></author><author><name sortKey="Jiping Zhu" sort="Jiping Zhu" uniqKey="Jiping Zhu" last="Jiping Zhu">JIPING ZHU</name><affiliation><inist:fA14 i1="01"><s1>Exposure and Biomonitoring Division, Health Canada</s1><s2>Ottawa, Ontario K1A 0K9</s2><s3>CAN</s3><sZ>1 aut.</sZ><sZ>3 aut.</sZ><sZ>6 aut.</sZ></inist:fA14></affiliation></author></analytic><series><title level="j" type="main">Environmental science & technology</title><title level="j" type="abbreviated">Environ. sci. technol.</title><idno type="ISSN">0013-936X</idno><imprint><date when="2014">2014</date></imprint></series></biblStruct></sourceDesc><seriesStmt><title level="j" type="main">Environmental science & technology</title><title level="j" type="abbreviated">Environ. sci. technol.</title><idno type="ISSN">0013-936X</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Biological fluid</term><term>Breast milk</term><term>Bromine Organic compounds</term><term>Canada</term><term>Concentration measurement</term><term>Emerging pollutant</term><term>Flame retardant</term><term>Health and environment</term><term>Milk transfer</term><term>Mother</term><term>Organic bromine compounds</term><term>Public health</term></keywords><keywords scheme="Pascal" xml:lang="fr"><term>Retardateur flamme</term><term>Brome composé organique</term><term>Brome Composé organique</term><term>Passage lait</term><term>Santé publique</term><term>Santé et environnement</term><term>Mesure concentration</term><term>Liquide biologique</term><term>Mère</term><term>Lait maternel</term><term>Canada</term><term>Polluant émergent</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">We have examined several emerging brominated flame retardants (BFRs) including 2-ethyl-1-hexyl-2,3,4,5-tetrabromobenzoate (TBB), bis(2-ethylhexyl) tetrabromophthalate (TBPH), 1,2-bis(2,4,6-tribromophenoxy) ethane (BTBPE), 4,5,6,7-tetrabromo-1,1,3-trimethyl-3-(2,3,4,5-tetrabromophenyl)-indane (OBIND), and decabromodiphenyl ethane (DBDPE) in paired human maternal serum (n = 102) and breast milk (n = 105) collected in 2008-2009 in the Sherbrooke region in Canada. Three legacy BFRs were also included in the study for comparison: decabromobiphenyl (BB-209), 2,2',4,4',5,5'-hexabromobiphenyl (BB-153), and 2,2',4,4',5,5'-hexabromodiphenyl ethers (BDE-153). TBB, BB-153, and BDE-153 had detection frequencies greater than 55% in both serum and milk samples. Their lipid weight (lw) adjusted median concentrations (ng g<sup>-1 </sup>lw) in serum and milk were 1.6 and 0.41 for TBB, 0.48 and 0.31 for BB-153, and 1.5 and 4.4 for BDE-153, respectively. The detection frequencies for the other BFRs measured in serum and milk were 16.7% and 32.4% for TBPH, 3.9% and 0.0% for BTBPE, 2.0% and 0.0% for BB-209, 9.8% and 1.0% for OBIND, and 5.9% and 8.6% for DBDPE. The ratio of TBB over the sum of TBB and TBPH (f.<sub>TBB</sub>) in serum (0.23) was lower than that in milk (0.46), indicating TBB has a larger tendency than TBPH to be redistributed from blood to milk. Overall, these data confirm the presence of non-PBDE BFRs in humans, and the need to better understand their sources, routes of exposure, and potential human health effects.</div></front></TEI><inist><standard h6="B"><pA><fA01 i1="01" i2="1"><s0>0013-936X</s0></fA01><fA02 i1="01"><s0>ESTHAG</s0></fA02><fA03 i2="1"><s0>Environ. sci. technol.</s0></fA03><fA05><s2>48</s2></fA05><fA06><s2>15</s2></fA06><fA08 i1="01" i2="1" l="ENG"><s1>Measurements of Selected Brominated Flame Retardants in Nursing Women: Implications for Human Exposure</s1></fA08><fA09 i1="01" i2="1" l="ENG"><s1>Understanding the Risks of Unconventional Shale Gas Development</s1></fA09><fA11 i1="01" i2="1"><s1>NINGSUN ZHOU (Simon)</s1></fA11><fA11 i1="02" i2="1"><s1>BUCHAR (Angelina)</s1></fA11><fA11 i1="03" i2="1"><s1>SIDDIQUE (Shabana)</s1></fA11><fA11 i1="04" i2="1"><s1>TAKSER (Larissa)</s1></fA11><fA11 i1="05" i2="1"><s1>ABDELOUAHAB (Nadia)</s1></fA11><fA11 i1="06" i2="1"><s1>JIPING ZHU</s1></fA11><fA12 i1="01" i2="1"><s1>STERN (Paul C.)</s1><s9>limin.</s9></fA12><fA12 i1="02" i2="1"><s1>WEBLER (Thomas)</s1><s9>limin.</s9></fA12><fA12 i1="03" i2="1"><s1>SMALL (Mitchell J.)</s1><s9>limin.</s9></fA12><fA14 i1="01"><s1>Exposure and Biomonitoring Division, Health Canada</s1><s2>Ottawa, Ontario K1A 0K9</s2><s3>CAN</s3><sZ>1 aut.</sZ><sZ>3 aut.</sZ><sZ>6 aut.</sZ></fA14><fA14 i1="02"><s1>Existing Substances Risk Assessment Bureau, Health Canada</s1><s2>Ottawa, Ontario K1A 0K9</s2><s3>CAN</s3><sZ>2 aut.</sZ></fA14><fA14 i1="03"><s1>Département de Pédiatrie, Faculté de Médecine, Université de Sherbrooke</s1><s2>Sherbrooke, Québec J1K 2R1</s2><s3>CAN</s3><sZ>4 aut.</sZ><sZ>5 aut.</sZ></fA14><fA15 i1="01"><s1>National Research Council, Board on Environmental Change and Society</s1><s2>Washington, DC20001</s2><s3>USA</s3><sZ>1 aut.</sZ></fA15><fA15 i1="02"><s1>Social and Environmental Research Institute</s1><s2>Amherst, Massachusetts 01002</s2><s3>USA</s3><sZ>2 aut.</sZ></fA15><fA15 i1="03"><s1>H. John Heinz III Professor of Environmental Engineering, Carnegie Mellon University</s1><s2>Pittsburgh, Pennsylvania 15213</s2><s3>USA</s3><sZ>3 aut.</sZ></fA15><fA20><s1>8873-8880</s1></fA20><fA21><s1>2014</s1></fA21><fA23 i1="01"><s0>ENG</s0></fA23><fA43 i1="01"><s1>INIST</s1><s2>13615</s2><s5>354000504883950660</s5></fA43><fA44><s0>0000</s0><s1>© 2015 INIST-CNRS. All rights reserved.</s1></fA44><fA45><s0>56 ref.</s0></fA45><fA47 i1="01" i2="1"><s0>15-0038201</s0></fA47><fA60><s1>P</s1></fA60><fA61><s0>A</s0></fA61><fA64 i1="01" i2="1"><s0>Environmental science & technology</s0></fA64><fA66 i1="01"><s0>USA</s0></fA66><fC01 i1="01" l="ENG"><s0>We have examined several emerging brominated flame retardants (BFRs) including 2-ethyl-1-hexyl-2,3,4,5-tetrabromobenzoate (TBB), bis(2-ethylhexyl) tetrabromophthalate (TBPH), 1,2-bis(2,4,6-tribromophenoxy) ethane (BTBPE), 4,5,6,7-tetrabromo-1,1,3-trimethyl-3-(2,3,4,5-tetrabromophenyl)-indane (OBIND), and decabromodiphenyl ethane (DBDPE) in paired human maternal serum (n = 102) and breast milk (n = 105) collected in 2008-2009 in the Sherbrooke region in Canada. Three legacy BFRs were also included in the study for comparison: decabromobiphenyl (BB-209), 2,2',4,4',5,5'-hexabromobiphenyl (BB-153), and 2,2',4,4',5,5'-hexabromodiphenyl ethers (BDE-153). TBB, BB-153, and BDE-153 had detection frequencies greater than 55% in both serum and milk samples. Their lipid weight (lw) adjusted median concentrations (ng g<sup>-1 </sup>lw) in serum and milk were 1.6 and 0.41 for TBB, 0.48 and 0.31 for BB-153, and 1.5 and 4.4 for BDE-153, respectively. The detection frequencies for the other BFRs measured in serum and milk were 16.7% and 32.4% for TBPH, 3.9% and 0.0% for BTBPE, 2.0% and 0.0% for BB-209, 9.8% and 1.0% for OBIND, and 5.9% and 8.6% for DBDPE. The ratio of TBB over the sum of TBB and TBPH (f.<sub>TBB</sub>) in serum (0.23) was lower than that in milk (0.46), indicating TBB has a larger tendency than TBPH to be redistributed from blood to milk. Overall, these data confirm the presence of non-PBDE BFRs in humans, and the need to better understand their sources, routes of exposure, and potential human health effects.</s0></fC01><fC02 i1="01" i2="X"><s0>002B03L06</s0></fC02><fC03 i1="01" i2="X" l="FRE"><s0>Retardateur flamme</s0><s5>02</s5></fC03><fC03 i1="01" i2="X" l="ENG"><s0>Flame retardant</s0><s5>02</s5></fC03><fC03 i1="01" i2="X" l="SPA"><s0>Retardador llama</s0><s5>02</s5></fC03><fC03 i1="02" i2="3" l="FRE"><s0>Brome composé organique</s0><s5>03</s5></fC03><fC03 i1="02" i2="3" l="ENG"><s0>Organic bromine compounds</s0><s5>03</s5></fC03><fC03 i1="03" i2="X" l="FRE"><s0>Brome Composé organique</s0><s2>NC</s2><s2>FR</s2><s2>FX</s2><s2>NA</s2><s5>05</s5></fC03><fC03 i1="03" i2="X" l="ENG"><s0>Bromine Organic compounds</s0><s2>NC</s2><s2>FR</s2><s2>FX</s2><s2>NA</s2><s5>05</s5></fC03><fC03 i1="03" i2="X" l="SPA"><s0>Bromo Compuesto orgánico</s0><s2>NC</s2><s2>FR</s2><s2>FX</s2><s2>NA</s2><s5>05</s5></fC03><fC03 i1="04" i2="X" l="FRE"><s0>Passage lait</s0><s5>06</s5></fC03><fC03 i1="04" i2="X" l="ENG"><s0>Milk transfer</s0><s5>06</s5></fC03><fC03 i1="04" i2="X" l="SPA"><s0>Paso leche</s0><s5>06</s5></fC03><fC03 i1="05" i2="X" l="FRE"><s0>Santé publique</s0><s5>08</s5></fC03><fC03 i1="05" i2="X" l="ENG"><s0>Public health</s0><s5>08</s5></fC03><fC03 i1="05" i2="X" l="SPA"><s0>Salud pública</s0><s5>08</s5></fC03><fC03 i1="06" i2="X" l="FRE"><s0>Santé et environnement</s0><s5>09</s5></fC03><fC03 i1="06" i2="X" l="ENG"><s0>Health and environment</s0><s5>09</s5></fC03><fC03 i1="06" i2="X" l="SPA"><s0>Salud y medio ambiente</s0><s5>09</s5></fC03><fC03 i1="07" i2="X" l="FRE"><s0>Mesure concentration</s0><s5>11</s5></fC03><fC03 i1="07" i2="X" l="ENG"><s0>Concentration measurement</s0><s5>11</s5></fC03><fC03 i1="07" i2="X" l="SPA"><s0>Medición concentración</s0><s5>11</s5></fC03><fC03 i1="08" i2="X" l="FRE"><s0>Liquide biologique</s0><s5>12</s5></fC03><fC03 i1="08" i2="X" l="ENG"><s0>Biological fluid</s0><s5>12</s5></fC03><fC03 i1="08" i2="X" l="SPA"><s0>Líquido biológico</s0><s5>12</s5></fC03><fC03 i1="09" i2="X" l="FRE"><s0>Mère</s0><s5>16</s5></fC03><fC03 i1="09" i2="X" l="ENG"><s0>Mother</s0><s5>16</s5></fC03><fC03 i1="09" i2="X" l="SPA"><s0>Madre</s0><s5>16</s5></fC03><fC03 i1="10" i2="X" l="FRE"><s0>Lait maternel</s0><s5>17</s5></fC03><fC03 i1="10" i2="X" l="ENG"><s0>Breast milk</s0><s5>17</s5></fC03><fC03 i1="10" i2="X" l="SPA"><s0>Leche materna</s0><s5>17</s5></fC03><fC03 i1="11" i2="X" l="FRE"><s0>Canada</s0><s2>NG</s2><s5>18</s5></fC03><fC03 i1="11" i2="X" l="ENG"><s0>Canada</s0><s2>NG</s2><s5>18</s5></fC03><fC03 i1="11" i2="X" l="SPA"><s0>Canadá</s0><s2>NG</s2><s5>18</s5></fC03><fC03 i1="12" i2="X" l="FRE"><s0>Polluant émergent</s0><s4>CD</s4><s5>96</s5></fC03><fC03 i1="12" i2="X" l="ENG"><s0>Emerging pollutant</s0><s4>CD</s4><s5>96</s5></fC03><fC07 i1="01" i2="X" l="FRE"><s0>Amérique du Nord</s0><s2>NG</s2></fC07><fC07 i1="01" i2="X" l="ENG"><s0>North America</s0><s2>NG</s2></fC07><fC07 i1="01" i2="X" l="SPA"><s0>America del norte</s0><s2>NG</s2></fC07><fC07 i1="02" i2="X" l="FRE"><s0>Amérique</s0><s2>NG</s2></fC07><fC07 i1="02" i2="X" l="ENG"><s0>America</s0><s2>NG</s2></fC07><fC07 i1="02" i2="X" l="SPA"><s0>America</s0><s2>NG</s2></fC07><fC07 i1="03" i2="X" l="FRE"><s0>Composé organique</s0><s2>NA</s2><s5>61</s5></fC07><fC07 i1="03" i2="X" l="ENG"><s0>Organic compounds</s0><s2>NA</s2><s5>61</s5></fC07><fC07 i1="03" i2="X" l="SPA"><s0>Compuesto orgánico</s0><s2>NA</s2><s5>61</s5></fC07><fN21><s1>075</s1></fN21></pA></standard><server><NO>PASCAL 15-0038201 INIST</NO><ET>Measurements of Selected Brominated Flame Retardants in Nursing Women: Implications for Human Exposure</ET><AU>NINGSUN ZHOU (Simon); BUCHAR (Angelina); SIDDIQUE (Shabana); TAKSER (Larissa); ABDELOUAHAB (Nadia); JIPING ZHU; STERN (Paul C.); WEBLER (Thomas); SMALL (Mitchell J.)</AU><AF>Exposure and Biomonitoring Division, Health Canada/Ottawa, Ontario K1A 0K9/Canada (1 aut., 3 aut., 6 aut.); Existing Substances Risk Assessment Bureau, Health Canada/Ottawa, Ontario K1A 0K9/Canada (2 aut.); Département de Pédiatrie, Faculté de Médecine, Université de Sherbrooke/Sherbrooke, Québec J1K 2R1/Canada (4 aut., 5 aut.); National Research Council, Board on Environmental Change and Society/Washington, DC20001/Etats-Unis (1 aut.); Social and Environmental Research Institute/Amherst, Massachusetts 01002/Etats-Unis (2 aut.); H. John Heinz III Professor of Environmental Engineering, Carnegie Mellon University/Pittsburgh, Pennsylvania 15213/Etats-Unis (3 aut.)</AF><DT>Publication en série; Niveau analytique</DT><SO>Environmental science & technology; ISSN 0013-936X; Coden ESTHAG; Etats-Unis; Da. 2014; Vol. 48; No. 15; Pp. 8873-8880; Bibl. 56 ref.</SO><LA>Anglais</LA><EA>We have examined several emerging brominated flame retardants (BFRs) including 2-ethyl-1-hexyl-2,3,4,5-tetrabromobenzoate (TBB), bis(2-ethylhexyl) tetrabromophthalate (TBPH), 1,2-bis(2,4,6-tribromophenoxy) ethane (BTBPE), 4,5,6,7-tetrabromo-1,1,3-trimethyl-3-(2,3,4,5-tetrabromophenyl)-indane (OBIND), and decabromodiphenyl ethane (DBDPE) in paired human maternal serum (n = 102) and breast milk (n = 105) collected in 2008-2009 in the Sherbrooke region in Canada. Three legacy BFRs were also included in the study for comparison: decabromobiphenyl (BB-209), 2,2',4,4',5,5'-hexabromobiphenyl (BB-153), and 2,2',4,4',5,5'-hexabromodiphenyl ethers (BDE-153). TBB, BB-153, and BDE-153 had detection frequencies greater than 55% in both serum and milk samples. Their lipid weight (lw) adjusted median concentrations (ng g<sup>-1 </sup>lw) in serum and milk were 1.6 and 0.41 for TBB, 0.48 and 0.31 for BB-153, and 1.5 and 4.4 for BDE-153, respectively. The detection frequencies for the other BFRs measured in serum and milk were 16.7% and 32.4% for TBPH, 3.9% and 0.0% for BTBPE, 2.0% and 0.0% for BB-209, 9.8% and 1.0% for OBIND, and 5.9% and 8.6% for DBDPE. The ratio of TBB over the sum of TBB and TBPH (f.<sub>TBB</sub>) in serum (0.23) was lower than that in milk (0.46), indicating TBB has a larger tendency than TBPH to be redistributed from blood to milk. Overall, these data confirm the presence of non-PBDE BFRs in humans, and the need to better understand their sources, routes of exposure, and potential human health effects.</EA><CC>002B03L06</CC><FD>Retardateur flamme; Brome composé organique; Brome Composé organique; Passage lait; Santé publique; Santé et environnement; Mesure concentration; Liquide biologique; Mère; Lait maternel; Canada; Polluant émergent</FD><FG>Amérique du Nord; Amérique; Composé organique</FG><ED>Flame retardant; Organic bromine compounds; Bromine Organic compounds; Milk transfer; Public health; Health and environment; Concentration measurement; Biological fluid; Mother; Breast milk; Canada; Emerging pollutant</ED><EG>North America; America; Organic compounds</EG><SD>Retardador llama; Bromo Compuesto orgánico; Paso leche; Salud pública; Salud y medio ambiente; Medición concentración; Líquido biológico; Madre; Leche materna; Canadá</SD><LO>INIST-13615.354000504883950660</LO><ID>15-0038201</ID></server></inist></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Amérique/explor/PittsburghV1/Data/PascalFrancis/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000060 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Corpus/biblio.hfd -nk 000060 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Amérique
|area= PittsburghV1
|flux= PascalFrancis
|étape= Corpus
|type= RBID
|clé= Pascal:15-0038201
|texte= Measurements of Selected Brominated Flame Retardants in Nursing Women: Implications for Human Exposure
}}
| This area was generated with Dilib version V0.6.38. |  |